Purchase Order HT001415P1790

This is a $3,438.00 firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA), a defense agency, to Lifecell Corporation, a for-profit manufacturer. The contract has an ultimate completion date of April 27, 2015 and was awarded on April 24, 2015. The contract does not have a set-aside designation. Based on the contract description "0608001 SP100125-302", this appears to be for the delivery of a specific product or service, though the original solicitation...

This firm fixed-price purchase order for $5,283 was awarded by the Defense Health Agency (DHA) to Lifecell Corporation, a division of Allergan, Inc. The contract is for the delivery of 102020 3X7 ALLODERM .52-1.02 products, with a final completion date of September 4, 2015. This contract does not have a set-aside designation. Lifecell Corporation is a for-profit manufacturer of goods, and this award represents their most recent federal contract with the DHA, with their previous federal...

<p>This federal contract award was issued by the Defense Health Agency, a defense agency, to Lifecell Corporation, a for-profit manufacturer. The $101,492.00 firm fixed price purchase order is for an item with the description 2030002, and has an ultimate completion date of November 7, 2014. The contract does not have a set-aside designation. No additional details about the requested products or services, or the larger contract vehicle, were provided.</p>

<p>This federal contract award with ID HT001416P0324 was issued by the Defense Health Agency, a defense agency, to Lifecell Corporation, a for-profit manufacturer, for $93,587.00 on a firm fixed price purchase order. The award does not have a set-aside designation. The contract is for an item described as 2040002 20X40 SP100208-010, with a completion date of December 29, 2015. No further details about the specific products or services being provided are included in the information given.</p>

<p>The Defense Health Agency awarded a firm-fixed-price blanket purchase agreement (BPA) call to Lifecell Corporation, a division of Allergan, Inc., to provide medical implants and instruments such as screws, bolts, plates, rods, and drill bits. The contract has a potential value of $700,000.00 and a completion date of November 8, 2018. The award was made on November 9, 2017, and the place of performance is Bethesda, Maryland. This contract was not set aside for any specific business type.</p>

This federal contract award is for the purchase of ALLODERM (RTU) CONTOUR MEDIUM, IMPLANT by the Bureau of Medicine and Surgery, a Defense agency. The $106,236.00 firm fixed price purchase order was awarded to Lifecell Corporation, a for-profit manufacturer, on September 8, 2016. The contract has a period of performance through September 30, 2016 and does not utilize a set-aside designation. The contract was awarded by the Bureau of Medicine and Surgery, which is a component of the U.S. Navy.

This federal contract award was made by the Defense Health Agency, a defense agency, to Lifecell Corporation, a for-profit manufacturer of goods. The contract, with a ceiling value of $78,582.00, is for the procurement of 2540002-STRATTICE 25 X 40CM products. The contract type is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing structure. The place of performance is Bethesda, MD. The contract has no set-aside designation and the ultimate completion date is June 14, 2016.

This contract was awarded by the Defense Health Agency to Lifecell Corporation, a division of Allergan, Inc., a for-profit manufacturer of goods. The contract is for the provision of implants and medical instruments, including screws, bolts, plates, rods, and drill bits. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. The potential value of the contract is $125,000.00, and the place of performance is Bethesda, Maryland. The contract does not have...

<p>The U.S. Department of the Navy's Bureau of Medicine and Surgery awarded a Firm Fixed Price purchase order contract to LifeCell Corporation, a division of Allergan, Inc., for the delivery of STRATTICE RECONSTRUCTIVE TISSUE. The contract has a ceiling value of $3,574.00 and a completion date of May 20, 2015. The contract was not set aside for any particular business type. No additional details about a larger vehicle or major subcontractors were provided.</p>

This is a federal contract award from the Medical Command (MEDCOM), a major subordinate command of the U.S. Army, to LifeCell Corporation, a division of Allergan, Inc. The contract is for the procurement of allograft tissue and bones, with a ceiling value of $110,000. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. The period of performance runs through September 30, 2016. The place of performance is Colorado Springs, CO. There is no set-aside...